Cardurion Pharmaceuticals

Edit info

Founded: 2017

Location: Boston, MA

Employee range: 11 - 50

Clinical stage: Clin2

Therapy area: Heart failure

Drug types: CVV

Lead product: CRD-740

cardurion.com

linkedin.com

job board

Business:

Cardiovascular treatments

Drug notes:

CRD-4730 Clin1 catecholaminergic polymorphic ventricular tachycardia; undisclosed Clin0 heart failure; 2 undisclosed programs RD atrial fibrillation, cardiovascular disease

About:

Cardurion Pharmaceuticals is a next-generation cardiovascular biotech company founded by Dr. Michael E. Mendelsohn, a physician-Scientist with over 150 published articles. They focus on therapeutics that target cardiac myocyte signaling pathways to treat heart failure and other cardiovascular diseases. Cardurion Pharmaceuticals has facilities in Burlington, Massachusetts and Shonan, Japan.